Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NUFIRI-bev vs FOLFIRI-bev in Previously Treated Unresectable Metastatic Colorectal Cancer
NCT05678257Phase 2Terminated
- Sponsor
- NuCana
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of fosifloxuridine nafalbenamide in colorectal cancer (CRC), sponsored by NuCana. Started Apr 2023; status: terminated.
02
Drugs
fosifloxuridine nafalbenamide
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05678257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05678257.